Factors responsible for fluctuations in human NK cell activity in vitro. 1983

Y M Zaretskaya, and R A Burkhanov, and A G Dolbin, and K T Metodiev

The activity of NK cells in 12 healthy male donors was studied after 4, 8, 12, 16 and 20 h incubation of killer (mononuclear) cells with K562 target cells; a modification of the standard 3-5 h NK assay was used without preliminary centrifugation of the plates. The results indicated that 4 or 8 h incubation of killer and target cells (ratio 50:1) did not achieve maximum activity of NK cells. A significant increase in activity was found up to 12 h incubation. It was noted that variation in values decreased as the incubation time increased. The optimal incubation period was 16 h at which time maximum 51Cr release and least variation were registered. Longer incubation of K562 cells also contributed to their higher sensitivity to NK cells. The experimental data revealed in vitro factors responsible for fluctuations in the level of lytic NK activity in repeated assays in the same healthy donors.

UI MeSH Term Description Entries
D007694 Killer Cells, Natural Bone marrow-derived lymphocytes that possess cytotoxic properties, classically directed against transformed and virus-infected cells. Unlike T CELLS; and B CELLS; NK CELLS are not antigen specific. The cytotoxicity of natural killer cells is determined by the collective signaling of an array of inhibitory and stimulatory CELL SURFACE RECEPTORS. A subset of T-LYMPHOCYTES referred to as NATURAL KILLER T CELLS shares some of the properties of this cell type. NK Cells,Natural Killer Cells,Cell, NK,Cell, Natural Killer,Cells, NK,Cells, Natural Killer,Killer Cell, Natural,NK Cell,Natural Killer Cell
D008297 Male Males
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D003601 Cytotoxicity Tests, Immunologic The demonstration of the cytotoxic effect on a target cell of a lymphocyte, a mediator released by a sensitized lymphocyte, an antibody, or complement. AHG-CDC Tests,Anti-Human Globulin Complement-Dependent Cytotoxicity Tests,Microcytotoxicity Tests,Anti Human Globulin Complement Dependent Cytotoxicity Tests,Anti-Human Globulin Complement-Dependent Cytotoxicity Test,Antiglobulin-Augmented Lymphocytotoxicity Test,Antiglobulin-Augmented Lymphocytotoxicity Tests,Cytotoxicity Test, Immunologic,Cytotoxicity Tests, Anti-Human Globulin Complement-Dependent,Cytotoxicity Tests, Immunological,Immunologic Cytotoxicity Test,Immunologic Cytotoxicity Tests,Lymphocytotoxicity Test, Antiglobulin-Augmented,Lymphocytotoxicity Tests, Antiglobulin-Augmented,Microcytotoxicity Test,AHG CDC Tests,AHG-CDC Test,Anti Human Globulin Complement Dependent Cytotoxicity Test,Antiglobulin Augmented Lymphocytotoxicity Test,Antiglobulin Augmented Lymphocytotoxicity Tests,Cytotoxicity Test, Immunological,Cytotoxicity Tests, Anti Human Globulin Complement Dependent,Immunological Cytotoxicity Test,Immunological Cytotoxicity Tests,Lymphocytotoxicity Test, Antiglobulin Augmented,Lymphocytotoxicity Tests, Antiglobulin Augmented
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

Y M Zaretskaya, and R A Burkhanov, and A G Dolbin, and K T Metodiev
July 2016, Transplantation direct,
Y M Zaretskaya, and R A Burkhanov, and A G Dolbin, and K T Metodiev
January 1981, Medical microbiology and immunology,
Y M Zaretskaya, and R A Burkhanov, and A G Dolbin, and K T Metodiev
January 2013, Current protocols in immunology,
Y M Zaretskaya, and R A Burkhanov, and A G Dolbin, and K T Metodiev
January 1993, Life sciences,
Y M Zaretskaya, and R A Burkhanov, and A G Dolbin, and K T Metodiev
November 1996, Rinsho byori. The Japanese journal of clinical pathology,
Y M Zaretskaya, and R A Burkhanov, and A G Dolbin, and K T Metodiev
January 1995, Bollettino della Societa italiana di biologia sperimentale,
Y M Zaretskaya, and R A Burkhanov, and A G Dolbin, and K T Metodiev
June 1984, Clinical immunology and immunopathology,
Y M Zaretskaya, and R A Burkhanov, and A G Dolbin, and K T Metodiev
February 1985, Journal of reproductive immunology,
Y M Zaretskaya, and R A Burkhanov, and A G Dolbin, and K T Metodiev
January 2022, PloS one,
Y M Zaretskaya, and R A Burkhanov, and A G Dolbin, and K T Metodiev
June 1986, Shi yan sheng wu xue bao,
Copied contents to your clipboard!